REFERENCES
- Nussenblatt R B, Whitcup S M. Uveitis: Fundamentals and clinical practice. Behçet's disease. 3rd ed., R B. Nussenblatt. Mosby, Philadelphia 2004; 350–371
- Foster C S, Vitale A T. Diagnosis and treatment of uveitis. Adamantiades—Behçet's disease. 1st ed., P Zafirakis, C S Foster. W.B. Saunders, Philadelphia 2002; 632–652
- Özertürk Y, Bardak Y, Durmus M. Vitreoretinal surgery in Behçet's disease with severe ocular complications. Acta Ophthalmol Scand. 2001; 79: 192–196, [CSA]
- Soylu M, Demircan N, Pelit A. Pars plana vitrectomy in ocular Behçet's disease. Int Ophthalmol. 2001; 24: 219–223, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Heiligenhaus A, Bornfeld N, Foester M H, Wessing A. Long-term results of pars plana vitrectomy in the management of complicated uveitis. Br J Ophthalmol. 1994; 78: 549–554, [PUBMED], [INFOTRIEVE], [CSA]
- Scott R A, Haynes R J, Orr G M. Vitreous surgery in the management of chronic endogenous posterior uveitis. Eye. 2003; 17: 221–227, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Starvou P, Baldtatzis S, Letko E. Pars plana vitrectomy in patients with intermediate uveitis. Ocul Immunol Inflamm. 2001; 9: 141–151, [CSA], [CROSSREF]
- Fox G M, Flynn H W, Davis J L, Culbertson W. Causes of reduced visual acuity on long-term follow-up after cataract extraction in patients with uveitis and juvenile rheumatoid arthritis. Am J Ophthalmol. 1992; 114: 708–714, [PUBMED], [INFOTRIEVE], [CSA]
- Bovey E H, Herbort C P. Pars plana vitrectomy in the management of uveitis. Ocul Immunol Inflamm. 2000; 8: 285–191, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Chan C C, Matterson D M, Li Q, Whitcup S M, Nussenblatt R B. Apoptosis in patients with posterior uveitis. Arch Ophthalmol. 1997; 115: 1559–1567, [PUBMED], [INFOTRIEVE], [CSA]
- International Study Group for Behçet's disease. Criteria for diagnosis of Behçet's disease. Lancet. 1990; 335: 1078–1080, [CSA]
- Bloch-Michel E, Nussenblatt R B. International Uveitis Study Group recommendations for the evaluation of intraocular inflammatory disease. Am J Ophthalmol. 1987; 103: 234–235, [PUBMED], [INFOTRIEVE], [CSA]
- Marmor M F, Arden G B, Nilsson S EG, Zrenner E. Standard for clinical electroretinography. Arch Ophthalmol. 1989; 98: 1823–1828, [CSA]
- Potter M J, Myckatyn S O, Maberley A L, Lee A S. Vitrectomy for pars planitis complicated by vitreous hemorrhage: visual outcome and long-term follow-up. Am J Ophthalmol. 2001; 131: 514–515, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Kaplan H J, Waldrep J C, Chan W C, Nichelson J K, Wright J D. Human sympathetic ophthalmia. Immunologic analysis of the vitreous and uvea. Arch Ophthalmol. 1986; 104: 240–244, [PUBMED], [INFOTRIEVE], [CSA]
- Van Gelder R N, Kaplan H J. Diagnostic and therapeutic vitrectomy for uveitis. Retina, 3rd ed., S J. Ryan. Mosby, Philadelphia 2001; 2264–2269
- Sonoda K H, Enaida H, Ueno A. Pars plana vitrectomy assisted by triamcinolone acetonide for refractory uveitis: a case series study. Br J Ophthalmol. 2003; 87: 1012–1014, [CSA], [CROSSREF]
- Chalam K V, Malkani S, Shah V A. Intravitreal dexamethasone effectively reduces postoperative inflammation after vitreoretinal surgery. Ocul Immunol Inflamm. 2003; 34: 188–192, [CSA]
- Radetzky S, Walter P, Fauser S. Visual outcomes of patients with macular edema after pars plana vitrectomy and indocyanine green-assisted peeling of the internal membrane limiting membrane. Graefe's Arch Clin Exp Ophthalmol. 2004; 242: 273–278, [CSA], [CROSSREF]
- Dugel P U, Rao N A, Ozler S, Ligget P E, Smith R E. Pars plana vitrectomy for intraocular inflammation-related cystoid macular edema unresponsive to corticosteroids. Ophthalmology. 1992; 99: 1535–1541, [PUBMED], [INFOTRIEVE], [CSA]
- Kiryo J, Kita M, Tamde T. Pars plana vitrectomy for cystoid macular edema secondary to sarcoid uveitis. Ophthalmology. 2001; 108: 1140–1144, [CSA], [CROSSREF]
- Bakri S J, Beer P M. The effect of intravitreal triamcinolone acetonide on intraocular pressure. Ophthalmic Surg Lasers Imaging. 2003; 34: 386–390, [PUBMED], [INFOTRIEVE], [CSA]
- Gillies M C, Simpson J M, Billson F A. Safety of an intravitreal injection of triamcinolone. Arch Ophthalmol. 2004; 122: 336–340, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]